Hereditary Hemorrhagic Telangiectasia (HHT) Center

The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.

• NAICS93.110

• HRSA-26-092 Final.pdf

  application/pdf477 KB
  Download
• HRSA 26-092 HHT Center Program FAQ.pdf

  application/pdf83 KB
  Download

• Health Resources and Services Administration
  nwilliams1@hrsa.gov301-443-7432